Annual EBIT
-$5.69 M
+$15.40 M+73.03%
December 31, 2023
Summary
- As of February 8, 2025, FRTX annual earnings before interest & taxes is -$5.69 million, with the most recent change of +$15.40 million (+73.03%) on December 31, 2023.
- During the last 3 years, FRTX annual EBIT has risen by +$15.22 million (+72.80%).
- FRTX annual EBIT is now -216.06% below its all-time high of -$1.80 million, reached on December 1, 1990.
Performance
FRTX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$1.24 M
-$3.34 M-158.84%
December 31, 2023
Summary
- As of February 8, 2025, FRTX quarterly earnings before interest & taxes is -$1.24 million, with the most recent change of -$3.34 million (-158.84%) on December 31, 2023.
- Over the past year, FRTX quarterly EBIT has dropped by -$3.34 million (-158.84%).
- FRTX quarterly EBIT is now -107.55% below its all-time high of $16.39 million, reached on September 1, 2011.
Performance
FRTX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$5.69 M
+$3.29 M+36.61%
December 31, 2023
Summary
- As of February 8, 2025, FRTX TTM earnings before interest & taxes is -$5.69 million, with the most recent change of +$3.29 million (+36.61%) on December 31, 2023.
- Over the past year, FRTX TTM EBIT has increased by +$3.29 million (+36.61%).
- FRTX TTM EBIT is now -537.62% below its all-time high of $1.30 million, reached on September 1, 1990.
Performance
FRTX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
FRTX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +73.0% | -158.8% | +36.6% |
| 3 y3 years | +72.8% | -158.8% | +36.6% |
| 5 y5 years | +71.0% | -158.8% | +36.6% |
FRTX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +85.6% | -158.8% | +86.8% | at high | +85.7% |
| 5 y | 5-year | at high | +85.6% | -158.8% | +90.7% | at high | +86.0% |
| alltime | all time | -216.1% | +85.9% | -107.5% | +90.7% | -537.6% | +86.0% |
Fresh Tracks Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$5.69 M(-73.0%) | -$1.24 M(-158.8%) | -$5.69 M(-36.6%) |
| Sep 2023 | - | $2.10 M(-192.2%) | -$8.97 M(-47.5%) |
| Jun 2023 | - | -$2.28 M(-46.6%) | -$17.10 M(+7.1%) |
| Mar 2023 | - | -$4.27 M(-5.5%) | -$15.96 M(-24.3%) |
| Dec 2022 | -$21.09 M(-46.5%) | -$4.52 M(-24.8%) | -$21.09 M(-6.8%) |
| Sep 2022 | - | -$6.02 M(+425.6%) | -$22.63 M(-24.2%) |
| Jun 2022 | - | -$1.15 M(-87.8%) | -$29.87 M(-25.0%) |
| Mar 2022 | - | -$9.41 M(+55.1%) | -$39.84 M(+1.1%) |
| Dec 2021 | -$39.41 M(+88.4%) | - | - |
| Dec 2021 | - | -$6.06 M(-54.2%) | -$39.41 M(-3.2%) |
| Sep 2021 | - | -$13.25 M(+19.2%) | -$40.71 M(+28.1%) |
| Jun 2021 | - | -$11.12 M(+23.9%) | -$31.78 M(+23.3%) |
| Mar 2021 | - | -$8.97 M(+21.8%) | -$25.78 M(+23.3%) |
| Dec 2020 | -$20.91 M(-4.0%) | -$7.37 M(+70.2%) | -$20.91 M(-13.9%) |
| Sep 2020 | - | -$4.33 M(-15.5%) | -$24.30 M(+2.7%) |
| Jun 2020 | - | -$5.12 M(+24.8%) | -$23.65 M(+9.8%) |
| Mar 2020 | - | -$4.10 M(-61.8%) | -$21.54 M(-1.2%) |
| Dec 2019 | -$21.78 M(+10.9%) | -$10.75 M(+191.8%) | -$21.79 M(+45.3%) |
| Sep 2019 | - | -$3.68 M(+22.7%) | -$14.99 M(-2.5%) |
| Jun 2019 | - | -$3.00 M(-31.1%) | -$15.37 M(-12.2%) |
| Mar 2019 | - | -$4.36 M(+10.3%) | -$17.50 M(-10.9%) |
| Dec 2018 | -$19.65 M(+46.8%) | -$3.95 M(-2.8%) | -$19.65 M(+0.4%) |
| Sep 2018 | - | -$4.07 M(-20.7%) | -$19.58 M(+4.7%) |
| Jun 2018 | - | -$5.13 M(-21.1%) | -$18.69 M(+10.1%) |
| Mar 2018 | - | -$6.50 M(+67.5%) | -$16.97 M(+26.8%) |
| Dec 2017 | -$13.39 M(+45.9%) | -$3.88 M(+22.0%) | -$13.39 M(+9.0%) |
| Sep 2017 | - | -$3.18 M(-6.7%) | -$12.28 M(+5.2%) |
| Jun 2017 | - | -$3.41 M(+17.1%) | -$11.67 M(+21.8%) |
| Mar 2017 | - | -$2.91 M(+5.0%) | -$9.58 M(+4.4%) |
| Dec 2016 | -$9.18 M(-2.4%) | -$2.77 M(+7.9%) | -$9.18 M(+4.0%) |
| Sep 2016 | - | -$2.57 M(+94.6%) | -$8.82 M(+34.0%) |
| Jun 2016 | - | -$1.32 M(-47.4%) | -$6.59 M(-18.3%) |
| Mar 2016 | - | -$2.51 M(+3.6%) | -$8.06 M(-14.3%) |
| Dec 2015 | -$9.40 M(-43.4%) | -$2.42 M(+627.3%) | -$9.40 M(-19.4%) |
| Sep 2015 | - | -$333.00 K(-88.1%) | -$11.66 M(-25.8%) |
| Jun 2015 | - | -$2.79 M(-27.6%) | -$15.73 M(-7.5%) |
| Mar 2015 | - | -$3.86 M(-17.6%) | -$17.00 M(+2.2%) |
| Dec 2014 | -$16.63 M(-47.0%) | -$4.68 M(+6.5%) | -$16.63 M(+17.4%) |
| Sep 2014 | - | -$4.40 M(+8.1%) | -$14.17 M(-28.3%) |
| Jun 2014 | - | -$4.07 M(+16.7%) | -$19.75 M(-22.6%) |
| Mar 2014 | - | -$3.48 M(+56.8%) | -$25.53 M(-18.6%) |
| Dec 2013 | -$31.35 M(+33.8%) | -$2.22 M(-77.7%) | -$31.35 M(-14.6%) |
| Sep 2013 | - | -$9.98 M(+1.4%) | -$36.71 M(+6.4%) |
| Jun 2013 | - | -$9.84 M(+5.8%) | -$34.51 M(+5.8%) |
| Mar 2013 | - | -$9.31 M(+22.8%) | -$32.60 M(+39.1%) |
| Dec 2012 | -$23.43 M(+199.6%) | -$7.58 M(-2.6%) | -$23.43 M(+2.3%) |
| Sep 2012 | - | -$7.78 M(-2.0%) | -$22.90 M(-1904.8%) |
| Jun 2012 | - | -$7.94 M(+5569.3%) | $1.27 M(+68.1%) |
| Mar 2012 | - | -$140.00 K(-98.0%) | $755.00 K(-109.7%) |
| Dec 2011 | -$7.82 M(-74.9%) | -$7.05 M(-143.0%) | -$7.82 M(-2.8%) |
| Sep 2011 | - | $16.39 M(-294.0%) | -$8.05 M(-74.2%) |
| Jun 2011 | - | -$8.45 M(-3.1%) | -$31.25 M(-0.2%) |
| Mar 2011 | - | -$8.72 M(+19.9%) | -$31.30 M(+0.3%) |
| Dec 2010 | -$31.21 M(+9.3%) | -$7.27 M(+6.8%) | -$31.21 M(-0.4%) |
| Sep 2010 | - | -$6.81 M(-19.9%) | -$31.33 M(-0.8%) |
| Jun 2010 | - | -$8.51 M(-1.4%) | -$31.57 M(+9.3%) |
| Mar 2010 | - | -$8.63 M(+16.9%) | -$28.87 M(+1.1%) |
| Dec 2009 | -$28.56 M(-23.5%) | -$7.38 M(+4.8%) | -$28.56 M(-2.7%) |
| Sep 2009 | - | -$7.05 M(+21.4%) | -$29.35 M(-9.7%) |
| Jun 2009 | - | -$5.81 M(-30.2%) | -$32.49 M(-8.7%) |
| Mar 2009 | - | -$8.32 M(+1.7%) | -$35.56 M(-4.8%) |
| Dec 2008 | -$37.34 M(-7.3%) | -$8.18 M(-19.7%) | -$37.34 M(-4.2%) |
| Sep 2008 | - | -$10.19 M(+14.6%) | -$38.99 M(-0.2%) |
| Jun 2008 | - | -$8.88 M(-12.0%) | -$39.08 M(-1.1%) |
| Mar 2008 | - | -$10.10 M(+2.7%) | -$39.50 M(-1.9%) |
| Dec 2007 | -$40.26 M | -$9.83 M(-4.3%) | -$40.26 M(+1.3%) |
| Sep 2007 | - | -$10.27 M(+10.4%) | -$39.73 M(+5.3%) |
| Jun 2007 | - | -$9.30 M(-14.3%) | -$37.74 M(+17.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | -$10.86 M(+16.8%) | -$32.25 M(+22.1%) |
| Dec 2006 | -$26.42 M(+3.0%) | -$9.30 M(+12.4%) | -$26.42 M(+13.3%) |
| Sep 2006 | - | -$8.28 M(+116.6%) | -$23.32 M(+8.7%) |
| Jun 2006 | - | -$3.82 M(-23.9%) | -$21.45 M(-6.1%) |
| Mar 2006 | - | -$5.02 M(-19.0%) | -$22.86 M(-10.9%) |
| Dec 2005 | -$25.65 M(+2.0%) | -$6.20 M(-3.2%) | -$25.65 M(+6.0%) |
| Sep 2005 | - | -$6.41 M(+22.6%) | -$24.20 M(+2.9%) |
| Jun 2005 | - | -$5.22 M(-33.1%) | -$23.52 M(-0.9%) |
| Mar 2005 | - | -$7.82 M(+64.6%) | -$23.75 M(-5.6%) |
| Dec 2004 | -$25.14 M(-3.7%) | -$4.75 M(-17.2%) | -$25.14 M(-8.7%) |
| Sep 2004 | - | -$5.74 M(+5.3%) | -$27.55 M(+7.6%) |
| Jun 2004 | - | -$5.45 M(-40.9%) | -$25.60 M(-7.3%) |
| Mar 2004 | - | -$9.21 M(+28.8%) | -$27.62 M(+5.8%) |
| Dec 2003 | -$26.10 M(-17.5%) | -$7.15 M(+88.8%) | -$26.10 M(-4.1%) |
| Sep 2003 | - | -$3.79 M(-49.3%) | -$27.23 M(-21.3%) |
| Jun 2003 | - | -$7.47 M(-3.0%) | -$34.61 M(+4.5%) |
| Mar 2003 | - | -$7.70 M(-7.0%) | -$33.12 M(+4.7%) |
| Dec 2002 | -$31.63 M(+83.6%) | -$8.28 M(-25.9%) | -$31.63 M(+21.1%) |
| Sep 2002 | - | -$11.17 M(+87.1%) | -$26.11 M(+34.2%) |
| Jun 2002 | - | -$5.97 M(-3.8%) | -$19.46 M(+2.9%) |
| Mar 2002 | - | -$6.21 M(+125.0%) | -$18.90 M(+9.7%) |
| Dec 2001 | -$17.23 M(+6.6%) | -$2.76 M(-38.9%) | -$17.23 M(-8.9%) |
| Sep 2001 | - | -$4.52 M(-16.6%) | -$18.92 M(+1.8%) |
| Jun 2001 | - | -$5.42 M(+19.3%) | -$18.57 M(+14.4%) |
| Mar 2001 | - | -$4.54 M(+2.1%) | -$16.23 M(-0.7%) |
| Dec 2000 | -$16.16 M(+79.5%) | -$4.45 M(+6.5%) | -$16.34 M(+30.1%) |
| Sep 2000 | - | -$4.17 M(+35.9%) | -$12.56 M(+6.8%) |
| Jun 2000 | - | -$3.07 M(-33.9%) | -$11.76 M(-3.9%) |
| Mar 2000 | - | -$4.65 M(+601.7%) | -$12.23 M(+37.7%) |
| Dec 1999 | -$9.00 M(-8.2%) | -$662.50 K(-80.3%) | -$8.88 M(-18.7%) |
| Sep 1999 | - | -$3.37 M(-4.9%) | -$10.92 M(+9.8%) |
| Jun 1999 | - | -$3.55 M(+172.8%) | -$9.95 M(+0.5%) |
| Mar 1999 | - | -$1.30 M(-51.9%) | -$9.90 M(-1.0%) |
| Dec 1998 | -$9.80 M(+25.6%) | -$2.70 M(+12.5%) | -$10.00 M(+11.1%) |
| Sep 1998 | - | -$2.40 M(-31.4%) | -$9.00 M(+23.3%) |
| Jun 1998 | - | -$3.50 M(+150.0%) | -$7.30 M(+10.6%) |
| Mar 1998 | - | -$1.40 M(-17.6%) | -$6.60 M(-15.4%) |
| Dec 1997 | -$7.80 M(0.0%) | -$1.70 M(+142.9%) | -$7.80 M(-4.9%) |
| Sep 1997 | - | -$700.00 K(-75.0%) | -$8.20 M(-21.2%) |
| Jun 1997 | - | -$2.80 M(+7.7%) | -$10.40 M(+33.3%) |
| Mar 1997 | - | -$2.60 M(+23.8%) | -$7.80 M(0.0%) |
| Dec 1996 | -$7.80 M(+39.3%) | -$2.10 M(-27.6%) | -$7.80 M(0.0%) |
| Sep 1996 | - | -$2.90 M(+1350.0%) | -$7.80 M(+25.8%) |
| Jun 1996 | - | -$200.00 K(-92.3%) | -$6.20 M(-1.6%) |
| Mar 1996 | - | -$2.60 M(+23.8%) | -$6.30 M(+14.5%) |
| Dec 1995 | -$5.60 M(+3.7%) | -$2.10 M(+61.5%) | -$5.50 M(-1.8%) |
| Sep 1995 | - | -$1.30 M(+333.3%) | -$5.60 M(+1.8%) |
| Jun 1995 | - | -$300.00 K(-83.3%) | -$5.50 M(-5.2%) |
| Mar 1995 | - | -$1.80 M(-18.2%) | -$5.80 M(+3.6%) |
| Dec 1994 | -$5.40 M(+157.1%) | -$2.20 M(+83.3%) | -$5.60 M(+19.1%) |
| Sep 1994 | - | -$1.20 M(+100.0%) | -$4.70 M(-4.1%) |
| Jun 1994 | - | -$600.00 K(-62.5%) | -$4.90 M(-12.5%) |
| Mar 1994 | - | -$1.60 M(+23.1%) | -$5.60 M(+166.7%) |
| Dec 1993 | -$2.10 M(-4.5%) | -$1.30 M(-7.1%) | -$2.10 M(-63.2%) |
| Sep 1993 | - | -$1.40 M(+7.7%) | -$5.70 M(+67.6%) |
| Jun 1993 | - | -$1.30 M(-168.4%) | -$3.40 M(+183.3%) |
| Mar 1993 | - | $1.90 M(-138.8%) | -$1.20 M(-45.5%) |
| Dec 1992 | -$2.20 M(-4.3%) | -$4.90 M(-644.4%) | -$2.20 M(+57.1%) |
| Sep 1992 | - | $900.00 K(0.0%) | -$1.40 M(-17.6%) |
| Jun 1992 | - | $900.00 K(0.0%) | -$1.70 M(-15.0%) |
| Mar 1992 | - | $900.00 K(-122.0%) | -$2.00 M(-13.0%) |
| Dec 1991 | -$2.30 M(+27.8%) | -$4.10 M(-783.3%) | -$2.30 M(+76.9%) |
| Sep 1991 | - | $600.00 K(0.0%) | -$1.30 M(-7.1%) |
| Jun 1991 | - | $600.00 K(0.0%) | -$1.40 M(-12.5%) |
| Mar 1991 | - | $600.00 K(-119.4%) | -$1.60 M(-11.1%) |
| Dec 1990 | -$1.80 M | -$3.10 M(-720.0%) | -$1.80 M(-238.5%) |
| Sep 1990 | - | $500.00 K(+25.0%) | $1.30 M(+62.5%) |
| Jun 1990 | - | $400.00 K(0.0%) | $800.00 K(+100.0%) |
| Mar 1990 | - | $400.00 K | $400.00 K |
FAQ
- What is Fresh Tracks Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics annual EBIT year-on-year change?
- What is Fresh Tracks Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics quarterly EBIT year-on-year change?
- What is Fresh Tracks Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics TTM EBIT year-on-year change?
What is Fresh Tracks Therapeutics annual earnings before interest & taxes?
The current annual EBIT of FRTX is -$5.69 M
What is the all time high annual EBIT for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high annual earnings before interest & taxes is -$1.80 M
What is Fresh Tracks Therapeutics annual EBIT year-on-year change?
Over the past year, FRTX annual earnings before interest & taxes has changed by +$15.40 M (+73.03%)
What is Fresh Tracks Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of FRTX is -$1.24 M
What is the all time high quarterly EBIT for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high quarterly earnings before interest & taxes is $16.39 M
What is Fresh Tracks Therapeutics quarterly EBIT year-on-year change?
Over the past year, FRTX quarterly earnings before interest & taxes has changed by -$3.34 M (-158.84%)
What is Fresh Tracks Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of FRTX is -$5.69 M
What is the all time high TTM EBIT for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high TTM earnings before interest & taxes is $1.30 M
What is Fresh Tracks Therapeutics TTM EBIT year-on-year change?
Over the past year, FRTX TTM earnings before interest & taxes has changed by +$3.29 M (+36.61%)